Pharmacology

Justin Drake

Mentor: Michael Henry, PhD

Year Entered Into Program: 2003-2009

PhD Institution: University of Iowa, 2009

Research Description

  1. Drake JM, Gabriel CL, Henry MD.:  Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging. Clin Exp Metastasis. 22(8):674-684, 2005.  PMID: 16703413
  2. Weydert CJ, Esser AK, Mejia RA, Drake JM, Barnes JM, Henry MD.: Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles. Cancer Biol Ther. 8(8):720-729, 2009.  PMID: 19242129
  3. Drake JM, Danke JR, Henry MD.:  Bone-specific growth inhibition of prostate cancer metastasis by atrasentan. Cancer Biol Ther. 9(8):607-614, 2010.  PMID: 20139704
  4. Drake JM, Barnes JM, Madsen JM, Domann FE, Stipp CS, Henry MD.:  ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells. J Biol Chem 285(44):33940-33948, 2010.  PMCID: PMC2962494
  5. Varzavand A, Drake JM, Svensson RU, Herndon ME, Zhou B, Henry MD, Stipp CS.:  Integrin alpha3beta1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization. Clin Exp Metastasis 2012 Dec 6 [Epub ahead of print]. PMID: 23224938

 


Award(s)

  • Winner: 2006 Graduate Student Poster Session - Carver College of Medicine
  • Recipient of American Heart Association Predoctoral Fellowship, 2006-2007